Gisela Barbany

Publications
CV
Public outreach and news

Articles

Article: NPJ PRECISION ONCOLOGY. 2023;7(1):131
Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia
Krali O; Marincevic-Zuniga Y; Arvidsson G; Enblad AP; Lundmark A; Sayyab S; Zachariadis V; Heinaniemi M; Suhonen J; Oksa L; Vepsaelaeinen K; Ofverholm I; Barbany G; Nordgren A; Lilljebjorn H; Fioretos T; Madsen HO; Marquart HV; Flaegstad T; Forestier E; Jonsson OG; Kanerva J; Lohi O; Noren-Nystrom U; Schmiegelow K; Harila A; Heyman M; Lonnerholm G; Syvanen A-C; Nordlund J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;202(2):384-392
The prognostic impact of IKZF1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols
Ofverholm I; Rezayee F; Heyman M; Harila A; Arvidsson L; Schmiegelow K; Noren-Nystrom U; Barbany G
Article: CURRENT RESEARCH IN TRANSLATIONAL MEDICINE. 2023;71(3):103401
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation
Xagoraris I; Stathopoulou K; Aulerio RD; He M; Ketscher A; Jatta K; de Flon FH; Barbany G; Rosenquist R; Westerberg LS; Rassidakis GZ
Article: BLOOD. 2023;141(23):2853-2866
The clinical picture of ERCC6L2 disease: from bone marrow failure to acute leukemia
Hakkarainen M; Kaaja I; Douglas SPM; Vulliamy T; Dokal I; Soulier J; Larcher L; de Latour RP; Leblanc T; de Fontbrune FS; Siitonen T; Lohi O; Hellstrom-Lindberg E; Barbany G; Tesi B; Shimamura A; Beier F; Jackson S; Kuperman AA; Zaccai TF; Tamary H; Mecucci C; Capolsini I; Jahnukainen K; Salmenniemi U; Niinimaki R; Varilo T; Kilpivaara O; Wartiovaara-Kautto U
Article: CANCERS. 2023;15(7):1972
Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma
Arthur C; Jylha C; de Stahl TD; Shamikh A; Sandgren J; Rosenquist R; Nordenskjold M; Harila A; Barbany G; Sandvik U; Tham E
Article: FRONTIERS IN ONCOLOGY. 2023;13:1217712
Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia
Rezayee F; Eisfeldt J; Skaftason A; Ofverholm I; Sayyab S; Syvanen AC; Maqbool K; Lilljebjorn H; Johansson B; Olsson-Arvidsson L; Pietras CO; Staffas A; Palmqvist L; Fioretos T; Cavelier L; Fogelstrand L; Nordlund J; Wirta V; Rosenquist R; Barbany G
Article: HEMASPHERE. 2022;6(10):e785
Duplex Sequencing Uncovers Recurrent Low-frequency Cancer-associated Mutations in Infant and Childhood KMT2A-rearranged Acute Leukemia
Pilheden M; Ahlgren L; Hyrenius-Wittsten A; Gonzalez-Pena V; Sturesson H; Marquart HVH; Lausen B; Castor A; Pronk CJ; Barbany G; Tamm KP; Fogelstrand L; Lohi O; Noren-Nystrom U; Asklin J; Chen Y; Song G; Walsh M; Ma J; Zhang J; Saal LH; Gawad C; Hagstrom-Andersson AK
Article: LEUKEMIA. 2022;36(7):1834-1842
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
White HE; Salmon M; Albano F; Andersen CSA; Balabanov S; Balatzenko G; Barbany G; Cayuela J-M; Cerveira N; Cochaux P; Colomer D; Coriu D; Diamond J; Dietz C; Dulucq S; Engvall M; Franke GN; Gineikiene-Valentine E; Gniot M; Gomez-Casares MT; Gottardi E; Hayden C; Hayette S; Hedblom A; Ilea A; Izzo B; Jimenez-Velasco A; Jurcek T; Kairisto V; Langabeer SE; Lion T; Meggyesi N; Mesanovic S; Mihok L; Mitterbauer-Hohendanner G; Moeckel S; Naumann N; Nibourel O; Oppliger Leibundgut E; Panayiotidis P; Podgornik H; Pott C; Rapado I; Rose SJ; Schaefer V; Touloumenidou T; Veigaard C; Venniker-Punt B; Venturi C; Vigneri P; Vorkinn I; Wilkinson E; Zadro R; Zawada M; Zizkova H; Mueller MC; Saussele S; Ernst T; Machova Polakova K; Hochhaus A; Cross NCP
Article: BLOOD ADVANCES. 2022;6(7):2275-2289
A somatic UBA2 variant preceded ETV6-RUNX1 in the concordant BCP-ALL of monozygotic twins
Bang B; Eisfeldt J; Barbany G; Harila-Saari A; Heyman M; Zachariadis V; Taylan F; Nordgren A
Article: FRONTIERS IN PEDIATRICS. 2022;10:1082986
Case Report: Whole genome sequencing identifies CCDC88C as a novel JAK2 fusion partner in pediatric T-cell acute lymphoblastic leukemia
Krstic A; Rezayee F; Saft L; Hammarsjoe A; Svenberg P; Barbany G
Article: FRONTIERS IN ONCOLOGY. 2022;12:899325
Patient-Specific Assays Based on Whole-Genome Sequencing Data to Measure Residual Disease in Children With Acute Lymphoblastic Leukemia: A Proof of Concept Study
Arthur C; Rezayee F; Mogensen N; Saft L; Rosenquist R; Nordenskjold M; Harila-Saari A; Tham E; Barbany G
Article: FRONTIERS IN MEDICINE. 2022;9:842507
A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
Berglund E; Barbany G; Orsmark-Pietras C; Fogelstrand L; Abrahamsson J; Golovleva I; Hallbook H; Hoglund M; Lazarevic V; Levin L-A; Nordlund J; Noren-Nystrom U; Palle J; Thangavelu T; Palmqvist L; Wirta V; Cavelier L; Fioretos T; Rosenquist R; Clinical GPSGMS
Article: EJHAEM. 2021;2(4):813-817
Cytogenetic aberrations in adult acute lymphoblastic leukemia-A population-based study
Lennmyr EB; Engvall M; Barbany G; Fogelstrand L; Rhodin H; Hallbook H
Article: LANCET HAEMATOLOGY. 2021;8(10):e700-e710
Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study
Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML
Article: HAEMATOLOGICA. 2021;106(1):87-97
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
Leeksma AC; Baliakas P; Moysiadis T; Puiggros A; Plevova K; van der Kevie-Kersemaekers A-M; Posthuma H; Rodriguez-Vicente AE; Tran AN; Barbany G; Mansouri L; Gunnarsson R; Parker H; van den Berg E; Bellido M; Davis Z; Wall M; Scarpelli I; Osterborg A; Hansson L; Jarosova M; Ghia P; Poddighe P; Espinet B; Pospisilova S; Tam C; Ysebaert L; Nguyen-Khac F; Oscier D; Haferlach C; Schoumans J; Stevens-Kroef M; Eldering E; Stamatopoulos K; Rosenquist R; Strefford JC; Mellink C; Kater AP
Article: NEUROLOGY-GENETICS. 2020;6(6):e526
Heterozygous variants in DCC: Beyond congenital mirror movements
Thams S; Islam M; Lindefeldt M; Nordgren A; Granberg T; Tesi B; Barbany G; Nilsson D; Paucar M
Article: LEUKEMIA & LYMPHOMA. 2020;61(3):604-613
Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia
Ivanov Ofverholm I; Zachariadis V; Taylan F; Marincevic-Zuniga Y; Anh NT; Saft L; Nilsson D; Syvanen A-C; Lonnerholm G; Harila-Saari A; Nordenskjold M; Heyman M; Nordgren A; Nordlund J; Barbany G
Article: PEDIATRIC TRANSPLANTATION. 2019;23(4):e13408
Strong expression of p53 protein in bone marrow samples after hematopoietic stem cell transplantation indicates risk of relapse in pediatric acute lymphoblastic leukemia patients
Mattsson K; Honkaniemi E; Ramme K; Barbany G; Sander BM; Gustafsson BM
Article: BLOOD ADVANCES. 2019;3(2):148-157
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALL
Hamadeh L; Enshaei A; Schwab C; Alonso CN; Attarbaschi A; Barbany G; den Boer ML; Boer JM; Braun M; Dalla Pozza L; Elitzur S; Emerenciano M; Fechina L; Felice MS; Fronkova E; Haltrich I; Heyman MM; Horibe K; Imamura T; Jeison M; Kovacs G; Kuiper RP; Mlynarski W; Nebra K; Ofverholm IL; Pastorczak A; Pieters R; Piko H; Pombo-de-Oliveira MS; Rubio P; Strehl S; Stary J; Sutton R; Trka J; Tsaur G; Venn N; Vora A; Yano M; Harrison CJ; Moorman AV; Barbieri C; Barbosa TC; Dalzell P; Digiorge JA; Druy A; Granado ET; Marshall G; Meciany T; Ng A
Article: PLOS ONE. 2018;13(3):e0193928
High-resolution detection of chromosomal rearrangements in leukemias through mate pair whole genome sequencing
Anh NT; Taylan F; Zachariadis V; Ofverholm II; Lindstrand A; Vezzi F; Lotstedt B; Nordenskjold M; Nordgren A; Nilsson D; Barbany G
Article: BLOOD ADVANCES. 2017;1(19):1473-1477
Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?
Schwab C; Nebral K; Chilton L; Leschi C; Waanders E; Boer JM; Zaliova M; Sutton R; Ofverholm II; Ohki K; Yamashita Y; Groeneveld-Krentz S; Fronkova E; Bakkus M; Tchinda J; Barbosa TDC; Fazio G; Mlynarski W; Pastorczak A; Cazzaniga G; Pombo-de-Oliveira MS; Trka J; Kirschner-Schwabe R; Imamura T; Barbany G; Stanulla M; Attarbaschi A; Panzer-Gruemayer R; Kuiper RP; den Boer ML; Cave H; Moorman AV; Harrison CJ; Strehl S
Article: LEUKEMIA & LYMPHOMA. 2016;57(9):2161-2170
Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia
Ofverholm II; Anh NT; Olsson L; Zachariadis V; Heyman M; Rudd E; Lundberg ES; Nordenskjold M; Johansson B; Nordgren A; Barbany G
Article: CLINICAL CANCER RESEARCH. 2016;22(16):4030-4038
Leukemic Stem Cell Quantification in Newly Diagnosed Patients With Chronic Myeloid Leukemia Predicts Response to Nilotinib Therapy
Thielen N; Richter J; Baldauf M; Barbany G; Fioretos T; Giles F; Gjertsen B-T; Hochhaus A; Schuurhuis GJ; Sopper S; Stenke L; Thunberg S; Wolf D; Ossenkoppele G; Porkka K; Janssen J; Mustjoki S
Article: PEDIATRIC TRANSPLANTATION. 2015;19(7):767-775
Increased p53 protein expression as a potential predictor of early relapse after hematopoietic stem cell transplantation in children with acute myelogenous leukemia
Mattsson K; Honkaniemi E; Barbany G; Gustafsson B
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2015;170(6):847-858
The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013
Olsson L; Oefverholm II; Noren-Nystroem U; Zachariadis V; Nordlund J; Sjoegren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Article: NATURE GENETICS. 2015;47(6):672-676
The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia
Paulsson K; Lilljebjorn H; Biloglav A; Olsson L; Rissler M; Castor A; Barbany G; Fogelstrand L; Nordgren A; Sjogren H; Fioretos T; Johansson B
Article: LEUKEMIA. 2015;29(2):369-376
A certified plasmid reference material for the standardisation of BCR-ABL1 mRNA quantification by real-time quantitative PCR
White H; Deprez L; Corbisier P; Hall V; Lin F; Mazoua S; Trapmann S; Aggerholm A; Andrikovics H; Akiki S; Barbany G; Boeckx N; Bench A; Catherwood M; Cayuela J-M; Chudleigh S; Clench T; Colomer D; Daraio F; Dulucq S; Farrugia J; Fletcher L; Foroni L; Ganderton R; Gerrard G; Gineikiene E; Hayette S; El Housni H; Izzo B; Jansson M; Johnels P; Jurcek T; Kairisto V; Kizilors A; Kim D-W; Lange T; Lion T; Polakova KM; Martinelli G; McCarron S; Merle PA; Milner B; Mitterbauer-Hohendanner G; Nagar M; Nickless G; Nomdedeu J; Nymoen DA; Leibundgut EO; Ozbek U; Pajic T; Pfeifer H; Preudhomme C; Raudsepp K; Romeo G; Sacha T; Talmaci R; Touloumenidou T; Van der Velden VHJ; Waits P; Wang L; Wilkinson E; Wilson G; Wren D; Zadro R; Ziermann J; Zoi K; Mueller MC; Hochhaus A; Schimmel H; Cross NCP; Emons H
Article: CLINICAL EPIGENETICS. 2015;7(1):11
DNA methylation-based subtype prediction for pediatric acute lymphoblastic leukemia
Nordlund J; Backlin CL; Zachariadis V; Cavelier L; Dahlberg J; Ofverholm I; Barbany G; Nordgren A; Overnas E; Abrahamsson J; Flaegstad T; Heyman MM; Jonsson OG; Kanerva J; Larsson R; Palle J; Schmiegelow K; Gustafsson MG; Lonnerholm G; Forestier E; Syvanen A-C
Article: CANCER CELL. 2014;26(3):428-442
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
Zabriskie MS; Eide CA; Tantravahi SK; Vellore NA; Estrada J; Nicolini FE; Khoury HJ; Larson RA; Konopleva M; Cortes JE; Kantarjian H; Jabbour EJ; Kornblau SM; Lipton JH; Rea D; Stenke L; Barbany G; Lange T; Hernandez-Boluda J-C; Ossenkoppele GJ; Press RD; Chuah C; Goldberg SL; Wetzler M; Mahon F-X; Etienne G; Baccarani M; Soverini S; Rosti G; Rousselot P; Friedman R; Deininger M; Reynolds KR; Heaton WL; Eiring AM; Pomicter AD; Khorashad JS; Kelley TW; Baron R; Druker BJ; Deininger MW; O'Hare T
Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2014;31(4):327-339
Elevated p53 Protein Expression; A Predictor of Relapse in Rare Chronic Myeloid Malignancies in Children?
Honkaniemi E; Mattsson K; Barbany G; Sander B; Gustafsson B
Article: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2014;7:32
Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries
Lundin C; Forestier E; Andersen MK; Autio K; Barbany G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B
Article: HAEMATOLOGICA. 2013;98(9):1424-1432
High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols
Paulsson K; Forestier E; Andersen MK; Autio K; Barbany G; Borgstrom G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B
Article: LEUKEMIA. 2013;27(7):1520-1526
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
Mustjoki S; Richter J; Barbany G; Ehrencrona H; Fioretos T; Gedde-Dahl T; Gjertsen BT; Hovland R; Hernesniemi S; Josefsen D; Koskenvesa P; Dybedal I; Markevarn B; Olofsson T; Olsson-Stromberg U; Rapakko K; Thunberg S; Stenke L; Simonsson B; Porkka K; Hjorth-Hansen H
Article: PEDIATRIC TRANSPLANTATION. 2012;16(6):E241-E245
Donor cell-derived acute myeloid leukemia after second allogenic cord blood transplantation in a patient with Fanconi anemia
Gustafsson B; Moell J; LeBlanc K; Barbany G; Soderhall S; Winiarski J
Article: LEUKEMIA. 2012;26(8):1821-1828
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation
Lion T; Watzinger F; Preuner S; Kreyenberg H; Tilanus M; de Weger R; van Loon J; de Vries L; Cave H; Acquaviva C; Lawler M; Crampe M; Serra A; Saglio B; Colnaghi F; Biondi A; van Dongen JJM; van der Burg M; Gonzalez M; Alcoceba M; Barbany G; Hermanson M; Roosnek E; Steward C; Harvey J; Frommlet F; Bader P
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2012;87(8):760-765
Early landmark analysis of imatinib treatment in CML chronic phase: Less than 10% BCR-ABL by FISH at 3 months associated with improved long-term clinical outcome
Ohm L; Arvidsson I; Barbany G; Hast R; Stenke L
Article: LEUKEMIA RESEARCH. 2012;36(7):936-938
Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol
Barbany G; Andersen MK; Autio K; Borgstrom G; Franco LC; Golovleva I; Heim S; Heinonen K; Hovland R; Johansson B; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2012;21(4):645-657
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Couch FJ; Gaudet MM; Antoniou AC; Ramus SJ; Kuchenbaecker KB; Soucy P; Beesley J; Chen X; Wang X; Kirchhoff T; McGuffog L; Barrowdale D; Lee A; Healey S; Sinilnikova OM; Andrulis IL; Ozcelik H; Mulligan AM; Thomassen M; Gerdes A-M; Jensen UB; Skytte A-B; Kruse TA; Caligo MA; von Wachenfeldt A; Barbany-Bustinza G; Loman N; Soller M; Ehrencrona H; Karlsson P; Nathanson KL; Rebbeck TR; Domchek SM; Jakubowska A; Lubinski J; Jaworska K; Durda K; Zlowocka E; Huzarski T; Byrski T; Gronwald J; Cybulski C; Gorski B; Osorio A; Duran M; Isabel Tejada M; Benitez J; Hamann U; Hogervorst FBL; van Os TA; van Leeuwen FE; Meijers-Heijboer HEJ; Wijnen J; Blok MJ; Kets M; Hooning MJ; Oldenburg RA; Ausems MGEM; Peock S; Frost D; Ellis SD; Platte R; Fineberg E; Evans DG; Jacobs C; Eeles RA; Adlard J; Davidson R; Eccles DM; Cole T; Cook J; Paterson J; Brewer C; Douglas F; Hodgson SV; Morrison PJ; Walker L; Porteous ME; Kennedy MJ; Side LE; Bove B; Godwin AK; Stoppa-Lyonnet D; Fassy-Colcombet M; Castera L; Cornelis F; Mazoyer S; Leone M; Boutry-Kryza N; Bressac-de Paillerets B; Caron O; Pujol P; Coupier I; Delnatte C; Akloul L; Lynch HT; Snyder CL; Buys SS; Daly MB; Terry M; Chung WK; John EM; Miron A; Southey MC; Hopper JL; Goldgar DE; Singer CF; Rappaport C; Tea M-KM; Fink-Retter A; Hansen TVO; Nielsen FC; Arason A; Vijai J; Shah S; Sarrel K; Robson ME; Piedmonte M; Phillips K; Basil J; Rubinstein WS; Boggess J; Wakeley K; Ewart-Toland A; Montagna M; Agata S; Imyanitov EN; Isaacs C; Janavicius R; Lazaro C; Blanco I; Feliubadalo L; Brunet J; Gayther SA; Pharoah PPD; Odunsi KO; Karlan BY; Walsh CS; Olah E; Teo SH; Ganz PA; Beattie MS; van Rensburg EJ; Dorfling CM; Diez O; Kwong A; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Heidemann S; Niederacher D; Preisler-Adams S; Gadzicki D; Varon-Mateeva R; Deissler H; Gehrig A; Sutter C; Kast K; Fiebig B; Heinritz W; Caldes T; de la Hoya M; Muranen TA; Nevanlinna H; Tischkowitz M; Spurdle AB; Neuhausen SL; Ding YC; Lindor NM; Fredericksen Z; Pankratz VS; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Bernard L; Viel A; Giannini G; Varesco L; Radice P; Greene MH; Mai PL; Easton DF; Chenevix-Trench G; Offit K; Simard J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2011;155(2):235-243
Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols
Andersen MK; Autio K; Barbany G; Borgstroem G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
Article: BRITISH JOURNAL OF CANCER. 2011;104(8):1356-1361
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
Osorio A; Milne RL; Alonso R; Pita G; Peterlongo P; Teule A; Nathanson KL; Domchek SM; Rebbeck T; Lasa A; Konstantopoulou I; Hogervorst FB; Verhoef S; van Dooren MF; Jager A; Ausems MGEM; Aalfs CM; van Asperen CJ; Vreeswijk M; Waisfisz Q; Van Roozendaal CE; Ligtenberg MJ; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Curzon B; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Adlard J; Eccles D; Ong K-R; Douglas F; Downing S; Brewer C; Walker L; Nevanlinna H; Aittomaki K; Couch FJ; Fredericksen Z; Lindor NM; Godwin A; Isaacs C; Caligo MA; Loman N; Jernstrom H; Barbany-Bustinza G; Liljegren A; Ehrencrona H; Stenmark-Askmalm M; Feliubadalo L; Manoukian S; Peissel B; Zaffaroni D; Bonanni B; Fortuzzi S; Johannsson OT; Chenevix-Trench G; Chen X-C; Beesley J; Spurdle AB; Sinilnikova OM; Healey S; McGuffog L; Antoniou AC; Brunet J; Radice P; Benitez J
Article: BREAST CANCER RESEARCH. 2011;13(2):R40
Exploring the link between MORF4L1 and risk of breast cancer
Martrat G; Maxwell CA; Tominaga E; Porta-de-la-Riva M; Bonifaci N; Gomez-Baldo L; Bogliolo M; Lazaro C; Blanco I; Brunet J; Aguilar H; Fernandez-Rodriguez J; Seal S; Renwick A; Rahman N; Kuehl J; Neveling K; Schindler D; Ramirez MJ; Castella M; Hernandez G; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Chu C; Davidson R; Ong K-R; Cook J; Douglas F; Hodgson S; Brewer C; Morrison PJ; Porteous M; Peterlongo P; Manoukian S; Peissel B; Zaffaroni D; Roversi G; Barile M; Viel A; Pasini B; Ottini L; Putignano AL; Savarese A; Bernard L; Radice P; Healey S; Spurdle A; Chen X; Beesley J; Rookus MA; Verhoef S; Tilanus-Linthorst MA; Vreeswijk MP; Asperen CJ; Bodmer D; Ausems MGEM; van Os TA; Blok MJ; Meijers-Heijboer HEJ; Hogervorst FBL; Goldgar DE; Buys S; John EM; Miron A; Southey M; Daly MB; Harbst K; Borg A; Rantala J; Barbany-Bustinza G; Ehrencrona H; Stenmark-Askmalm M; Kaufman B; Laitman Y; Milgrom R; Friedman E; Domchek SM; Nathanson KL; Rebbeck TR; Johannsson OT; Couch FJ; Wang X; Fredericksen Z; Cuadras D; Moreno V; Pientka FK; Depping R; Caldes T; Osorio A; Benitez J; Bueren J; Heikkinen T; Nevanlinna H; Hamann U; Torres D; Caligo MA; Godwin AK; Imyanitov EN; Janavicius R; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Verny-Pierre C; Castera L; de Pauw A; Bignon Y-J; Uhrhammer N; Peyrat J-P; Vennin P; Ferrer SF; Collonge-Rame M-A; Mortemousque I; McGuffog L; Chenevix-Trench G; Pereira-Smith OM; Antoniou AC; Ceron J; Tominaga K; Surralles J; Angel Pujana M
Article: LEUKEMIA. 2011;25(4):622-628
The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial
Zachariadis V; Gauffin F; Kuchinskaya E; Heyman M; Schoumans J; Blennow E; Gustafsson B; Barbany G; Golovleva I; Ehrencrona H; Cavelier L; Palmqvist L; Lonnerholm G; Nordenskjold M; Johansson B; Forestier E; Nordgren A
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2010;85(5):399-404
Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph plus ALL receiving dasatinib
Olsson-Stromberg U; Hermansson M; Lundan T; Ohm A-C; Engdahl I; Hoglund M; Simonsson B; Porkka K; Barbany G
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2010;84(2):117-127
Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006
Thorn I; Forestier E; Thuresson B; Wasslavik C; Malec M; Li A; Lindstrom-Eriksson E; Botling J; Barbany G; Jacobsson S; Olofsson T; Porwit A; Sundstrom C; Rosenquist R
Article: HUMAN MOLECULAR GENETICS. 2009;18(22):4442-4456
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Antoniou AC; Sinilnikova OM; McGuffog L; Healey S; Nevanlinna H; Heikkinen T; Simard J; Spurdle AB; Beesley J; Chen X; Neuhausen SL; Ding YC; Couch FJ; Wang X; Fredericksen Z; Peterlongo P; Peissel B; Bonanni B; Viel A; Bernard L; Radice P; Szabo CI; Foretova L; Zikan M; Claes K; Greene MH; Mai PL; Rennert G; Lejbkowicz F; Andrulis IL; Ozcelik H; Glendon G; Gerdes A-M; Thomassen M; Sunde L; Caligo MA; Laitman Y; Kontorovich T; Cohen S; Kaufman B; Dagan E; Baruch RG; Friedman E; Harbst K; Barbany-Bustinza G; Rantala J; Ehrencrona H; Karlsson P; Domchek SM; Nathanson KL; Osorio A; Blanco I; Lasa A; Benitez J; Hamann U; Hogervorst FBL; Rookus MA; Collee JM; Devilee P; Ligtenberg MJ; van der Luijt RB; Aalfs CM; Waisfisz Q; Wijnen J; van Roozendaal CEP; Peock S; Cook M; Frost D; Oliver C; Platte R; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Cole T; Hodgson S; Godwin AK; Stoppa-Lyonnet D; Buecher B; Leone M; Bressac-de Paillerets B; Remenieras A; Caron O; Lenoir GM; Sevenet N; Longy M; Ferrer SF; Prieur F; Goldgar D; Miron A; John EM; Buys SS; Daly MB; Hopper JL; Terry MB; Yassin Y; Singer C; Gschwantler-Kaulich D; Staudigl C; Hansen TVO; Barkardottir RB; Kirchhoff T; Pal P; Kosarin K; Offit K; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov EN; Allavena A; Schmutzler RK; Versmold B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Deissler H; Fiebig B; Suttner C; Schoenbuchner I; Gadzicki D; Caldes T; de la Hoya M; Pooley KA; Easton DF; Chenevix-Trench G
Article: LEUKEMIA RESEARCH. 2009;33(8):1047-1054
Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia
Thorn I; Botling J; Hermansson M; Lonnerholm G; Sundstrom C; Rosenquist R; Barbany G
Article: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2009;47(12):1467-1469
Quantitation of RNA decay in dried blood spots during 20 years of storage
Gauffin F; Nordgren A; Barbany G; Gustafsson B; Karlsson H
Article: LEUKEMIA & LYMPHOMA. 2008;49(3):477-487
Characterization of 6q deletions in mature B cell lymphomas and childhood acute lymphoblastic leukemia
Thelander EF; Ichimura K; Corcoran M; Barbany G; Nordgren A; Heyman M; Berglund M; Mungall A; Rosenquist R; Collins VP; Grander D; Larsson C; Lagercrantz S
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2008;366(3):848-851
Expression of BCR-ABL1 oncogene relative to ABL1 gene changes overtime in chronic myeloid leukemia
Gupta M; Milani L; Hermansson M; Simonsson B; Markevarn B; Syvdnen AC; Barbany G
Article: LEUKEMIA RESEARCH. 2007;31(9):1219-1230
Detailed assessment of copy number alterations revealing homozygous deletions in 1p and 13q in mantle cell lymphoma
Thelander EF; Ichimura K; Collins VP; Walsh SH; Barbany G; Hagberg A; Laurell A; Rosenquist R; Larsson C; Lagercrantz S
Article: LEUKEMIA. 2007;21(7):1481-1487
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays:: towards new standards for gene expression measurements
Saldanha J; Silvy M; Beaufils N; Arlinghaus R; Barbany G; Branford S; Cayuela J-M; Cazzaniga G; Gonzalez M; Grimwade D; Kairisto V; Miyamura K; Lawler M; Lion T; Macintyre E; Mahon F-X; Muller MC; Ostergaard M; Pfeifer H; Saglio G; Sawyers C; Spinelli O; van der Velden VHJ; Wang JQ; Zoi K; Patel V; Phillips P; Matejtschuk P; Gabert J
Article: LEUKEMIA RESEARCH. 2007;31(7):931-938
Gene expression analysis identifies a genetic signature potentially associated with response to α-IFN in chronic phase CML patients
Hagberg A; Olsson-Stromberg U; Wickenberg-Bolin U; Goransson H; Isaksson A; Bengtsson M; Hoglund M; Simonsson B; Barbany G
Article: ANTI-CANCER DRUGS. 2006;17(6):631-639
Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis
Olsson-Stromberg U; Aleskog A; Bjornberg A; Hoglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
Article: HAEMATOLOGICA. 2005;90(11):1471-1476
The impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia
Thorn I; Olsson-Stromberg U; Ohlsen C; Jonsson A-M; Klangby U; Simonsson B; Barbany G
Article: ANTI-CANCER DRUGS. 2005;16(6):631-634
In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia
Hallböök H; Barbany G; Åleskog A; Björnberg A; Larsson R; Sundström C; Lindhagen E
Article: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 2005;49(4):488-493
Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat
Lennmyr F; Terént A; Syvänen AC; Barbany G
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2003;63(3):239-245
Beta-globin mRNA increases rapidly during erythropoietin treatment
Hagberg A; Barbany G; Landegren U; Birgegård G
Article: NUCLEIC ACIDS RESEARCH. 2001;29(2):578-581
RNA-templated DNA ligation for transcript analysis
Nilsson M; Antson DO; Barbany G; Landegren U
Article: CLINICAL CHEMISTRY. 2000;46(7):913-920
Manifold-assisted reverse transcription-PCR with real-time detection for measurement of the BCR-ABL fusion transcript in chronic myeloid leukemia patients
Barbany G; Hagberg A; Olsson-Strömberg U; Simonsson B; Syvänen AC; Landegren U
Article: NATURE BIOTECHNOLOGY. 2000;18(7):791-793
Enhanced detection and distinction of RNA by enzymatic probe ligation
Nilsson M; Barbany G; Antson DO; Gertow K; Landegren U
Article: NUCLEIC ACIDS RESEARCH. 2000;28(11):E54
Expression profiling across many samples via manifold-assisted mRNA processing.
Hagberg A; Barbany G; Krook H; Samiotaki M; Landegren U
Article: NEW BIOTECHNOLOGY. 1999;16(1-4):105-111
Molecular genetic applications of streptavidin-coated manifold supports
Barbany G; Hagberg A; Waldenström E; Landegren U
Show more

All other publications

Editorial comment: FRONTIERS IN ONCOLOGY. 2024;14:1368676
Editorial: Decoding the genome of acute lymphoblastic leukemia through genomic and transcriptomic approaches
Jimenez-Morales S; Rojas-Martinez A; Barbany G
Letter: HEMASPHERE. 2023;7(5):e883
Genetic Subtypes and Outcome of Patients Aged 1 to 45 Years Old With Acute Lymphoblastic Leukemia in the NOPHO ALL2008 Trial
Noren-Nystrom U; Andersen MK; Barbany G; Dirse V; Eilert-Olsen M; Engvall M; Harila-Saari A; Heyman M; Hovland R; Haikio S; Jonsson JJ; Karhu R; Kjeldsen E; Norberg A; Preiss BS; Pulkkinen K; Quist-Paulsen P; Rasanen H; Schmiegelow K; Seitsonen A; Sjogren H; Tammur P; Johansson B
Editorial comment: HAEMATOLOGICA. 2021;106(10):2783-2787
Successful pregnancies after transplantation of ovarian tissue retrieved and cryopreserved at time of childhood acute lymphoblastic leukemia - a case report
Rodriguez-Wallberg KA; Milenkovic M; Papaikonomou K; Keros V; Gustafsson B; Sergouniotis F; Wikander I; Perot R; Borgstrom B; Ljungman P; Barbany G
Letter: BLOOD CANCER JOURNAL. 2020;10(5):51
Parental origin of monosomic chromosomes in near-haploid acute lymphoblastic leukemia
Lundin-Strom KB; Strom K; Biloglav A; Barbany G; Behrendtz M; Castor A; Olsson-Arvidsson L; Johansson B
Review: JOURNAL OF INTERNAL MEDICINE. 2019;286(2):118-136
Cell-free tumour DNA testing for early detection of cancer - a potential future tool
Barbany G; Arthur C; Lieden A; Nordenskjold M; Rosenquist R; Tesi B; Wallander K; Tham E
Letter: CLINICAL CHEMISTRY. 2019;65(2):345-347
Somatic Structural Alterations in Childhood Leukemia Can Be Backtracked in Neonatal Dried Blood Spots by Use of Whole-Genome Sequencing and Digital PCR
Taylan F; Bang B; Ofverholm II; Anh-Nhi T; Heyman M; Barbany G; Zachariadis V; Nordgren A
Letter: HAEMATOLOGICA. 2016;101(1):e20-e23
PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia
Marincevic-Zuniga Y; Zachariadis V; Cavelier L; Castor A; Barbany G; Forestier E; Fogelstrand L; Heyman M; Abrahamsson J; Lonnerholm G; Nordgren A; Syvanen A-C; Nordlund J
Review: LEUKEMIA. 2015;29(5):999-1003
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia
Cross NCP; White HE; Colomer D; Ehrencrona H; Foroni L; Gottardi E; Lange T; Lion T; Polakova KM; Dulucq S; Martinelli G; Leibundgut EO; Pallisgaard N; Barbany G; Sacha T; Talmaci R; Izzo B; Saglio G; Pane F; Mueller MC; Hochhaus A
Letter: LEUKEMIA. 2014;28(1):196-198
Detecting dic(9;20)(p13.2;p11.2)-positive B-cell precursor acute lymphoblastic leukemia in a clinical setting using fluorescence in situ hybridization
Zachariadis V; Schoumans J; Ofverholm I; Barbany G; Halvardsson E; Forestier E; Johansson B; Nordenskjold M; Nordgren A
Letter: LEUKEMIA & LYMPHOMA. 2013;54(12):2742-2744
The ETV6/RUNX1 fusion transcript is not detected in RNA isolated from neonatal dried blood spots from children later diagnosed with the corresponding leukemia
Barbany G; Gauffin F; Ofverholm I; Karlsson H; Thorn I; Arvidson J; Heyman M; Gustafsson B; Nordgren A
Letter: LEUKEMIA. 2013;27(9):1936-1939
Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols
Ofverholm I; Tran AN; Heyman M; Zachariadis V; Nordenskjold M; Nordgren A; Barbany G
Letter: LEUKEMIA. 2013;27(1):248-250
Loss of chromosomes is the primary event in near-haploid and low-hypodiploid acute lymphoblastic leukemia
Safavi S; Forestier E; Golovleva I; Barbany G; Nord KH; Moorman AV; Harrison CJ; Johansson B; Paulsson K
Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2012;159(4):488-491
Homozygous deletions of CDKN2A are present in all dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation
Zachariadis V; Schoumans J; Barbany G; Heyman M; Forestier E; Johansson B; Nordenskjold M; Nordgren A
Meeting abstract: BLOOD. 2006;108(11):621
The EuroChimerism concept for a standardized approach to chimerism analysis following allogeneic stem cell transplantation.
Lion T; Tilanus M; Cave H; Lawler M; Serra A; Biondi A; van Dongen J; Gonzalez M; Barbany G; Roosnek E; Steward C; Bader P
Meeting abstract: BLOOD. 2005;106(11):4490
Impact of RNA stabilization on minimal residual disease assessment in chronic myeloid leukemia.
Thörn I; Olsson-Strömberg U; Ohlsen C; Jonsson AM; Klangby U; Bengt S; Barbany G
Letter: LEUKEMIA. 2004;18(4):884-886
Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease - a study within the Europe Against Cancer Program
van der Velden VHJ; Boeckx N; Gonzalez M; Malec M; Barbany G; Lion T; Gottardi E; Pallisgaard N; Beillard E; Hop WCJ; Hoogeveen PG; Gabert J; van Dongen JJM
Editorial comment: LEUKEMIA. 2004;18(2):255-266
Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles
Fredriksson M; Barbany G; Liljedahl U; Hermanson M; Kataja M; Syvänen AC
Review: LEUKEMIA. 2003;17(12):2318-2357
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
Gabert J; Beillard E; van der Velden VHJ; Bi W; Grimwade D; Pallisgaard N; Barbany G; Cazzaniga G; Cayuela JM; Cavé H; Pane F; Aerts JLE; De Micheli D; Thirion X; Pradel V; González M; Viehmann S; Malec M; Saglio G; van Dongen JJM
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2002;347(7):539-540
Complete molecular remission in chronic myelogenous leukemia after imatinib therapy
Barbany G; Höglund M; Simonsson B

Employments

Affiliated to Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, 2023-2026

Degrees and Education

Docent, karolinska institutet, 2004

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI